A landmark transaction is set to reshape the landscape of orthotics and prosthetics (O&P) and complex rehabilitation technology (CRT) in North America. Hanger Inc., a leading provider of O&P patient care services, has announced its intent to acquire Numotion, a premier provider of CRT and mobility products. The strategic combination, which will form "Hanger Numotion," is poised to establish an unparalleled platform dedicated to enhancing mobility and independence for over 1.5 million patients annually across the U.S. and Canada. The new entity will be controlled by Patient Square Capital, signaling a significant investment in the future of rehabilitative care.
Main Facts
A New Era in Mobility Solutions
In a move set to redefine patient care in the mobility sector, Hanger Inc. has unveiled plans to acquire Numotion, uniting two formidable forces in the orthotics and prosthetics (O&P) and complex rehabilitation technology (CRT) industries. This strategic amalgamation will result in the formation of Hanger Numotion, a comprehensive North American platform dedicated to delivering an integrated spectrum of mobility and independence solutions. The combined entity is projected to serve a staggering 1.5 million patients annually, marking a significant expansion in reach and service capabilities across the United States and Canada.
Hanger, Inc., renowned for its extensive network of O&P patient care services and innovative solutions, brings to the merger a deep-rooted legacy in restoring mobility through custom-fabricated devices. Complementing this, Numotion, a portfolio company of AEA Investors, stands as a market leader in complex rehabilitation technology, providing specialized mobility products and services crucial for individuals with significant mobility impairments. The union of these two specialized domains promises to create a seamless continuum of care, addressing a broader range of patient needs from initial prosthetic or orthotic fitting to advanced power mobility and adaptive equipment.
The transaction, structured as a cash acquisition of Numotion by Hanger, underscores a clear strategic intent to consolidate market leadership and leverage combined resources for accelerated growth and innovation. Upon completion, Hanger Numotion will be under the control of Patient Square Capital, a healthcare-focused investment firm, whose stewardship is expected to drive long-term strategic initiatives and enhance operational efficiencies. While unified under a new corporate umbrella, both Hanger and Numotion are committed to maintaining their distinct brand identities and preserving their respective clinical operations, ensuring continuity of trusted care for their existing patient bases. This approach is designed to harness the strengths of both organizations while minimizing disruption during the integration phase.
The Architects of the Merger
The leadership structure for the newly formed Hanger Numotion has been meticulously planned to ensure a smooth transition and capitalize on existing executive strengths. Following the close of the transaction, Mike Swinford, the highly respected CEO of Numotion, will assume the helm as CEO of the combined company. Swinford’s tenure at Numotion, which began in 2014, has been characterized by remarkable growth, strategic expansion, and successful diversification, transforming the company into a preeminent leader in mobility solutions. His extensive experience, which includes over two decades at GE and a leadership role as President and CEO of GE Healthcare Services, positions him uniquely to steer the integrated entity through its next phase of development.
Pete Stoy, the current CEO of Hanger Inc., has been instrumental in the company’s recent transformation and will play a critical role in the transition process. Stoy expressed immense pride in Hanger’s accomplishments since he joined in 2020, highlighting the establishment of a more integrated national platform and significant investments in people, technology, and capabilities. His confidence in Swinford’s leadership underscores a shared vision for the future and a collaborative approach to realizing the full potential of Hanger Numotion.
Patient-Centric Growth
The core rationale behind this monumental merger is rooted in an unwavering commitment to patient well-being and expanded access to care. By combining Hanger’s 925 U.S.-based O&P clinics with Numotion’s 200+ locations across North America, the new organization will boast an unparalleled geographic footprint. This expanded presence is expected to significantly improve accessibility to essential mobility solutions, particularly for underserved communities.
Beyond geographical reach, the strategic combination aims to foster greater scale and resources, enabling substantial investments in several critical areas. These include clinician development, ensuring that healthcare professionals have access to the latest training, tools, and technologies to deliver best-in-class care. Furthermore, the combined entity plans to accelerate product innovation, leveraging collective R&D capabilities to develop advanced O&P devices and CRT solutions that are more comfortable, functional, and integrated with emerging technologies. The ultimate goal is to empower more individuals to live with greater mobility, independence, and an enhanced quality of life, fulfilling a shared mission that underpins the entire strategic endeavor.
Chronology
A Decades-Long Legacy Meets Modern Innovation
The story of Hanger and Numotion, while culminating in this significant merger, is deeply rooted in decades of dedicated service within the healthcare sector. Hanger Inc. traces its origins back to the mid-19th century, founded by James Edward Hanger, the first amputee of the Civil War. His personal experience ignited a lifelong commitment to improving prosthetic care, leading to the establishment of what would become a cornerstone of the O&P industry. Over its extensive history, Hanger has evolved from a pioneering prosthetic provider into a comprehensive network offering a full spectrum of orthotic and prosthetic patient care services, consistently integrating technological advancements and clinical expertise. Its growth has been organic and strategic, marked by continuous investment in research, clinician training, and expanding its clinic footprint across the United States. This long-standing heritage has built a reputation for clinical excellence and patient-focused innovation.
Numotion, while a more recent entrant compared to Hanger’s extensive history, has rapidly established itself as a dominant force in complex rehabilitation technology (CRT) and mobility products. Formed through strategic consolidations and organic growth, Numotion has focused on providing customized, high-quality mobility solutions, including power wheelchairs, manual wheelchairs, seating and positioning systems, and other adaptive equipment. The company’s ascent was particularly accelerated under the leadership of Mike Swinford, who joined in 2014. Under his guidance, Numotion significantly scaled its business, expanding its geographical reach across the U.S. and Canada and diversifying its service offerings to meet the intricate needs of individuals requiring complex mobility solutions. Its backing by private equity firm AEA Investors further facilitated this growth, enabling substantial investments in infrastructure, technology, and market penetration.
The convergence of these two distinct yet complementary trajectories—Hanger’s deep clinical O&P expertise and Numotion’s specialized CRT product and service delivery—represents a natural evolution in the integrated care model. As healthcare increasingly emphasizes holistic patient journeys, the limitations of siloed services have become apparent. Both companies, independently, recognized the growing need for more comprehensive solutions that span the entire spectrum of mobility challenges. This shared understanding laid the groundwork for the discussions that would ultimately lead to this transformative merger.
The Road to Integration
The announcement of the acquisition is the culmination of extensive strategic discussions and due diligence between Hanger, Numotion, AEA Investors, and Patient Square Capital. While the specific timeline of negotiations remains confidential, it is evident that the process involved a thorough evaluation of synergistic opportunities, market positioning, and operational integration strategies. The decision to structure the deal as an acquisition of Numotion for cash by Hanger, with the combined entity ultimately controlled by Patient Square Capital, reflects a complex financial engineering aimed at optimizing value for all parties and ensuring robust backing for future growth.
Private equity firms like AEA Investors and Patient Square Capital play pivotal roles in such transactions. AEA Investors, as Numotion’s primary investor, would have been instrumental in preparing Numotion for this strategic exit, ensuring its operational excellence and market attractiveness. Patient Square Capital’s decision to take control of the combined company signals a strong belief in the long-term potential of the integrated platform and its ability to generate significant value in the growing healthcare mobility market. Their involvement provides the necessary capital and strategic guidance to navigate the complexities of integration and execute on ambitious growth plans.
Anticipated Milestones
The transaction is currently slated for completion in the fourth quarter of 2026, subject to customary closing conditions. This extended timeframe is typical for deals of this magnitude, allowing for meticulous regulatory reviews, including antitrust considerations, and comprehensive integration planning. Regulatory approvals are crucial to ensure fair competition within the healthcare mobility market, and both companies will be working closely with relevant authorities to facilitate a smooth process.
Post-closing, the immediate milestones will include the formal establishment of the Hanger Numotion leadership team under Mike Swinford, the initiation of strategic integration committees, and the careful alignment of operational processes. A key focus will be on maintaining continuity of patient care and employee engagement throughout the transition. The commitment to retain existing brands and clinical operations underscores a cautious, phased approach to integration, prioritizing stability and preserving the unique strengths of each legacy organization. Over the subsequent months and years, the combined company will embark on initiatives to harmonize IT systems, optimize supply chains, cross-train staff, and launch integrated patient care pathways, all while seeking to unlock the full synergistic potential of this historic merger.
Supporting Data
Market Landscape: Orthotics, Prosthetics, and Complex Rehabilitation Technology
The sectors of orthotics and prosthetics (O&P) and complex rehabilitation technology (CRT) represent critical segments within the broader healthcare market, driven by a confluence of demographic, medical, and technological factors. The global O&P market, for instance, has been valued at tens of billions of dollars, with steady growth projected over the next decade. This growth is primarily fueled by an aging global population, an increasing prevalence of chronic diseases such as diabetes (leading to amputations), vascular conditions, and musculoskeletal disorders, alongside a rise in traumatic injuries. Advances in surgical techniques and post-operative care also contribute to a greater number of individuals requiring O&P devices to regain functionality and quality of life.
Similarly, the CRT market, while distinct, exhibits parallel growth drivers. CRT focuses on highly customized, individually configured equipment designed to meet the unique medical, physical, and functional needs of individuals with severe disabilities and complex medical conditions. This includes specialized wheelchairs, seating and positioning systems, standing frames, and alternative communication devices. The demand for CRT is bolstered by a growing understanding of its role in preventing secondary complications, improving independence, and enhancing participation in daily activities for individuals with conditions like cerebral palsy, spinal cord injuries, multiple sclerosis, and amyotrophic lateral sclerosis (ALS).
The North American market, in particular, is a significant contributor to these global figures, characterized by advanced healthcare infrastructure, a strong emphasis on rehabilitative care, and a robust regulatory framework that, while complex, supports access to these essential services. The combination of Hanger and Numotion addresses these burgeoning market needs by creating a single, integrated provider capable of offering a seamless continuum of care from a custom prosthetic limb to an advanced power wheelchair.
Synergies and Strategic Advantages
The strategic advantages of the Hanger-Numotion merger are multifaceted, extending beyond mere market consolidation. Operationally, the combined entity stands to achieve significant synergies. By integrating their supply chains, Hanger Numotion can leverage greater purchasing power for materials and components, potentially leading to cost efficiencies and improved inventory management. The standardization of certain administrative functions, such as billing, human resources, and IT infrastructure, can also reduce overhead and streamline operations.
From a clinical perspective, the synergy is even more profound. Hanger’s deep expertise in O&P, particularly in areas like advanced prosthetics using microprocessors and sophisticated materials, complements Numotion’s proficiency in complex seating and mobility solutions. This integration means a patient who requires an advanced prosthetic leg might also need a specialized seating system for their wheelchair to accommodate the prosthesis and prevent pressure sores. A combined Hanger Numotion can offer a coordinated, holistic assessment and provision process, ensuring that all aspects of a patient’s mobility needs are addressed by a single, accountable entity. This integrated approach can lead to better patient outcomes, reduced readmissions, and a more streamlined patient experience.
Furthermore, the combined network of over 1,125 locations (925 Hanger O&P clinics and 200+ Numotion locations) creates an unparalleled distribution and service footprint. This extensive reach is crucial for serving a diverse patient population, particularly in rural or underserved areas where access to specialized care can be limited. The ability to cross-refer patients between O&P clinics and CRT providers within the same organizational structure simplifies the care pathway for both patients and referring physicians.
Investment in Innovation and Access
The scale afforded by the merger will empower Hanger Numotion to significantly increase investments in research and development (R&D). In the rapidly evolving fields of O&P and CRT, innovation is paramount. This includes advancements in 3D printing for custom orthoses and prostheses, the integration of artificial intelligence and robotics in prosthetic limbs, the development of lightweight and durable materials, and smart technologies for wheelchairs that offer enhanced navigation, safety, and user-friendliness. A larger, more resourced company can dedicate greater capital to these areas, accelerating the development and adoption of cutting-edge solutions that directly improve patient lives.
Moreover, the merger is expected to enhance access to care. Beyond the expanded physical footprint, greater resources can be allocated to patient advocacy, navigating complex insurance landscapes, and supporting programs that help patients overcome financial barriers to essential mobility devices. For clinicians, the combined organization can offer enhanced training programs, access to a wider array of technologies, and expanded career development opportunities, attracting and retaining top talent in a specialized field. This investment in human capital is critical for maintaining high standards of care and fostering a culture of continuous improvement.
Financial Underpinnings and Market Impact
The financial structure of the deal—an acquisition of Numotion for cash by Hanger, with Patient Square Capital taking control of the combined entity—is characteristic of private equity-backed strategic consolidations in the healthcare sector. Private equity firms often seek to invest in fragmented markets with strong growth potential, aiming to create larger, more efficient, and market-leading platforms. Patient Square Capital’s control signifies a long-term strategic investment, likely accompanied by a focus on operational improvements, market expansion, and eventually, a substantial return on investment.
For the broader market, this merger is a significant indicator of ongoing consolidation trends in specialized healthcare services. It suggests a move towards vertically integrated models where providers aim to control a larger portion of the patient journey, from diagnosis and prescription to fitting, maintenance, and long-term support. While this can lead to efficiencies and improved patient experience, it also raises questions about market concentration and potential impacts on competition. However, given the highly specialized and often localized nature of O&P and CRT services, the immediate impact on competitive dynamics is expected to be managed through regulatory oversight and the continued presence of numerous smaller, independent providers. The sheer size of Hanger Numotion, however, will undoubtedly set new benchmarks for service delivery and innovation within the industry.
Official Responses
Leadership’s Vision for a Combined Future
The announcement of the Hanger Numotion merger was accompanied by powerful statements from the key leaders involved, underscoring a shared vision for a future defined by expanded patient care, innovation, and enhanced independence. Their words reflect not only the strategic rationale behind the transaction but also the deeply personal commitment to improving lives that drives both organizations.
Swinford’s Strategic Mandate
Mike Swinford, the seasoned executive who will assume the role of CEO for the combined Hanger Numotion, articulated a clear and compelling vision for the new entity. "Our two companies share a fundamental belief in the role mobility can play in improving people’s lives," Swinford stated. This foundational alignment, he emphasized, is the bedrock upon which the integrated organization will build. "By bringing together our respective experience, capabilities, and passion to serve our customers and patients, we have an opportunity to build on each company’s strengths and help more people across their mobility journeys."
Swinford’s quote highlights the synergistic potential: combining Hanger’s clinical depth in O&P with Numotion’s leadership in CRT and mobility products. His focus on "mobility journeys" rather than isolated treatments speaks to a holistic approach to patient care, acknowledging that an individual’s needs evolve over time and require comprehensive, adaptive solutions. He also extended his gratitude to Pete Stoy for his leadership at Hanger, to AEA Investors for their "strong partnership and commitment" to Numotion, and to LLR for its "longstanding investment" in the company, acknowledging the collective effort that brought Numotion to this pivotal moment. Swinford’s background, including his extensive tenure at GE Healthcare Services, provides him with a unique perspective on scaling healthcare businesses and driving innovation, positioning him as a strong leader for this ambitious undertaking. His enthusiasm for "advanc[ing] our shared commitment to helping people live with greater mobility and independence" sets a clear mandate for the organization’s future.
Stoy Reflects on Hanger’s Transformation
Pete Stoy, the outgoing CEO of Hanger Inc., offered a reflective and forward-looking perspective on the merger. "I am incredibly proud of what our team has accomplished at Hanger and the transformation the business has undergone since I joined the company in 2020," Stoy remarked. His tenure has seen Hanger evolve into a "stronger, more integrated national platform," characterized by significant investments in its workforce, technology, and capabilities, all of which have positioned the company for sustained growth. This groundwork, laid under Stoy’s leadership, is critical for the successful integration and future expansion of Hanger Numotion.
Stoy expressed immense confidence in his successor, Mike Swinford, stating, "I have worked with Mike closely throughout this process, and I have tremendous confidence in his ability to lead Hanger Numotion following the close of the transaction." This endorsement from the outgoing CEO is vital for ensuring a smooth leadership transition and fostering trust within both organizations. He lauded Swinford as "an accomplished leader who shares our commitment to patients and our people," recognizing the alignment in values and strategic direction. Stoy believes Swinford is "well-positioned to build on Hanger’s momentum and realize the tremendous potential of the combined organization ahead," underscoring the belief that the merger is not just an additive process but a multiplicat ive one, unlocking new levels of growth and impact.
The Investor’s Perspective: Patient Square Capital and AEA
While direct quotes from Patient Square Capital and AEA Investors were not provided in the original summary, their involvement speaks volumes about their strategic perspectives. Patient Square Capital’s decision to take control of the combined entity signifies a robust belief in the long-term value creation potential within the O&P and CRT markets. As a healthcare-focused investment firm, Patient Square Capital likely sees Hanger Numotion as a critical platform to address unmet needs in patient mobility, leveraging its scale for operational efficiencies, technological advancement, and market expansion. Their investment is a vote of confidence in the combined leadership team and the synergistic power of the merger.
AEA Investors, as the selling portfolio company of Numotion, would view this transaction as a successful culmination of their investment strategy. Having nurtured Numotion’s growth and expansion since acquiring it, the sale to Hanger, under Patient Square Capital’s control, represents a strategic exit that validates their efforts in building a market-leading CRT provider. Their partnership with Numotion’s management, particularly Mike Swinford, has evidently positioned the company for this next phase of growth and integration, ensuring a strong return for their investors. The collective official responses paint a picture of a well-considered, strategically aligned merger poised to make a significant positive impact on the North American healthcare mobility landscape.
Implications
Transforming Patient Care and Access
The formation of Hanger Numotion carries profound implications for patient care. For individuals requiring mobility solutions, this merger promises a more integrated and streamlined experience. Patients often navigate complex healthcare systems, dealing with multiple providers for different aspects of their care—an orthotist for a brace, a prosthetist for a limb, and a CRT specialist for a wheelchair. This fragmented approach can lead to inefficiencies, communication gaps, and delays in receiving comprehensive solutions. Hanger Numotion aims to mitigate these challenges by offering a "one-stop shop" model, where patients can access a wider range of services and products under a single, coordinated care plan.
This integration is particularly beneficial for patients with multi-faceted needs, such as individuals with lower limb amputations who also require complex seating solutions for their wheelchairs, or children with cerebral palsy who need both orthotic intervention and specialized mobility equipment. The combined clinical expertise means that Hanger Numotion can provide holistic assessments, ensuring that all devices work synergistically to optimize function and comfort. The expanded geographic footprint, with over 1,125 locations across North America, will also significantly improve access to specialized care, particularly in areas where access to either O&P clinics or CRT providers might be limited. This enhanced accessibility can reduce travel burdens for patients and their families, leading to more consistent care and better long-term outcomes.
Impact on Clinicians and Workforce
For clinicians and the broader workforce within both Hanger and Numotion, the merger presents a mix of opportunities and potential adjustments. On the positive side, the combined entity will offer expanded career development pathways. Clinicians, including orthotists, prosthetists, physical therapists, occupational therapists, and ATPs (Assistive Technology Professionals), may have opportunities for cross-training, specialization in integrated care models, and advancement within a larger, more diverse organization. Access to a broader range of technologies and patient cases can enrich their professional experience and enhance their skill sets.
The increased resources from Patient Square Capital and the combined operational scale will also likely translate into greater investment in clinician training, continuing education, and access to state-of-the-art equipment and facilities. This can help attract and retain top talent in a highly specialized field. However, mergers of this scale inevitably bring challenges. These can include cultural integration, the harmonization of different operational protocols and IT systems, and potential anxieties among employees regarding roles and responsibilities. The commitment to maintain existing brands and clinical operations aims to mitigate some of these concerns by emphasizing continuity and minimizing immediate structural changes. Clear communication and proactive employee engagement strategies will be critical for a successful integration.
Industry Consolidation and Competition
The Hanger Numotion merger represents a significant event in the healthcare mobility industry, signaling a trend towards consolidation. This creates a powerful market leader with unparalleled scale and comprehensive service offerings. While this can lead to greater efficiencies and potentially higher standards of care, it also raises questions about the competitive landscape. Smaller, independent O&P clinics and CRT providers may face increased pressure to compete with the resources and reach of the combined entity.
However, the highly personalized and localized nature of O&P and CRT services means that smaller providers will likely continue to thrive by focusing on niche markets, specialized expertise, or strong community ties. The regulatory environment, particularly concerning antitrust laws, will also play a role in ensuring fair competition. This merger may also prompt other large players in the O&P or CRT space to consider similar strategic alliances or acquisitions to maintain their competitive position, potentially leading to further industry consolidation in the coming years. Ultimately, the long-term impact on competition will depend on how Hanger Numotion leverages its market position and whether its growth strategies foster innovation across the industry or lead to market dominance that stifles smaller players.
Regulatory Landscape and Future Outlook
The transaction’s projected closing in the fourth quarter of 2026 underscores the complexity of regulatory approvals required for a merger of this magnitude. Healthcare is a heavily regulated industry, and the combined entity will need to navigate various federal and state regulations, including those related to patient privacy (HIPAA), billing and reimbursement, and fair trade practices. Antitrust reviews by agencies like the Federal Trade Commission (FTC) or the Department of Justice (DOJ) will be crucial to ensure that the merger does not unduly reduce competition or harm consumers. The extended timeline allows for thorough scrutiny and the implementation of any necessary divestitures or conditions.
Looking ahead, Hanger Numotion is exceptionally well-positioned to capitalize on several macro trends. The increasing demand for personalized healthcare, the growth of telehealth solutions, and advancements in AI and robotics in rehabilitative technology all present significant opportunities. The combined entity’s scale will allow for greater investment in these areas, potentially leading to the development of next-generation mobility solutions and integrated digital health platforms that enhance patient engagement and remote monitoring. The control by Patient Square Capital also suggests a long-term strategic vision focused on sustainable growth, operational excellence, and maximizing value through continuous innovation and market leadership. The future of mobility and independence solutions in North America will undoubtedly be shaped by the emergence of this new powerhouse.
Potential Challenges and Opportunities
While the merger offers immense potential, it also comes with inherent challenges. Integrating two large organizations with distinct cultures, operational systems, and employee bases can be complex. Ensuring cultural alignment, harmonizing IT platforms, and consolidating supply chains without disrupting patient care or employee morale will require meticulous planning and execution. Effective communication and strong change management leadership will be paramount throughout the integration period.
However, the opportunities far outweigh these challenges. Hanger Numotion can become a global thought leader in rehabilitative care, setting new standards for clinical excellence, patient outcomes, and technological innovation. By pooling resources, they can drive research into areas like advanced neuroprosthetics, regenerative medicine applications in O&P, and more sophisticated, user-friendly CRT devices. The combined entity’s advocacy voice will also be significantly amplified, enabling it to influence policy, improve reimbursement structures, and champion greater access to essential mobility services for all individuals who need them. Ultimately, the Hanger Numotion merger is not just a business transaction; it is a strategic investment in the future of human mobility and independence, with the potential to profoundly impact millions of lives across North America.
